c-Myc-induced extrachromosomal elements carry active chromatin

Neoplasia

Volumn 5, Issue 2, 2003, Pages 110-120

  Smith, Greg ^a,b   Taylor Kashton, Cheryl ^a,b   Dushnicky, Len ^c   Symons, Stephen ^c   Wright, Jim ^a,b   Mai, Sabine ^a,b,d  

^a CANCERCARE MANITOBA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c CANADIAN GRAIN COMMISSION   (Canada)

^d UNIVERSITY OF MANITOBA   (Canada)

Author keywords

c Myc; Extrachromosomal elements; Gene amplification; Genomic instability; Histone modification

Indexed keywords

BROXURIDINE; CYCLINE; DIHYDROFOLATE REDUCTASE; HISTONE; HISTONE ANTIBODY;

ANIMAL CELL; ARTICLE; CHROMATIN; CHROMOSOME STRUCTURE; CONTROLLED STUDY; DEGRANULATION; EXTRACHROMOSOMAL ELEMENT; GENE AMPLIFICATION; GENE EXPRESSION; GENE INDUCTION; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; ONCOGENE C MYC; PRE B LYMPHOCYTE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; WESTERN BLOTTING;

EID: 0037351765     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1476-5586(03)80002-7     Document Type: Article

References (68)

1. Littlewood TD, Hancock DC, Danielian PS, Parker MG, and Evan GI (1995). A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res 23, 1686-90.
2. Prendergast GC (1999). Mechanisms of apoptosis by c-Myc. Oncogene 18, 2967-87.
3. Marcu KB, Bossone SA, and Patel AJ (1992). Myc function and regulation. Annu Rev Biochem 61, 809-60.
4. Claassen GF, and Hann SR (1999). Myc-mediated transformation: the repression connection. Oncogene 18, 2925-33.
5. Oster SK, Ho CS, Soucie EL, and Penn LZ (2002). The myc oncogenes: marvelous IY complex. Adv Cancer Res 84, 81-154.
6. Taub R, Kirsch I, Morton C, Lenoir GM, Swan D, Tronick S, Aaronson S, and Leder P (1982). Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma. Proc Natl Acad Sci USA 79, 7837-41.
7. Shen-Ong GLC, Keath EJ, Piccoli SP, and Cole MD (1982). Novel myc oncogene RNA from abortive immunoglobulin-gene recombination in mouse plasmacytomas. Cell 31, 443-80.
8. Pear WS, Wahlstrom G, Nelson SF, Axelson H, Szeles A, Wiener F, Bazin H, Klein G, and Sumegi J (1988). 6;7 Chromosomal translocation in spontaneously arising rat immunocytomas: evidence for c-myc breakpoint clustering and correlation between isotype expression and the c-myc target. Mol Cell Biol 8, 441-51.
9. Henriksson M, and Lüscher B (1996). Proteins of the Myc network: essential regulators of cell growth and differentiation. Adv Cancer Res 68, 109-82.
10. Dang CV (1999). c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol 19, 1-11.
11. Watson JD, Oster SK, Shago M, Khosravi F, and Penn LZ (2002). Identifying genes regulated in a Myc-dependent manner. J Biol Chem 277, 36921-30.
12. Ngo CV, Gee M, Akhtar N, Yu D, Volpert O, Auerbach R, and Thomas-Tikhonenko A (2000). An in vivo function for the transforming Myc protein: elicitation of the angiogenic phenotype. Cell Growth Differ 11, 201-10.
13. Brandvold KA, Neiman P, and Ruddell A (2000). Angiogenesis is an early event in the generation of myc-induced lymphomas. Oncogene 19, 2780-85.
14. Baudino TA, McKay C, Pendeville-Samain H, Nilsson JA, Maclean KH, White EL, Davis AC, Ihle JN, and Cleveland JL (2002). c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression. Genes Dev 16, 2530-43.
15. Bishop JM (1995). Cancer: the rise of the genetic paradigm. Genes Dev 9, 1309-15.
16. Nesbit CE, Tersak JM, and Prochownik EV (1999). MYC oncogenes and human neoplastic disease. Oncogene 18, 3004-16.
17. Classon M, Henriksson M, Klein G, and Hammasjold ML (1987). Elevated c-myc expression facilitates the replication of SV40 DNA in lymphoma cells. Nature 330, 272-74.
18. Denis N, Kitzis A, Kruh J, Dautry F, and Corcos D (1991). Stimulation of methotrexate resistance and dihydrofolate reductase gene amplification by c-myc. Oncogene 6, 1453-57.
19. Mai S (1994). Overexpression of c-myc precedes amplification of the gene encoding dihydrofolate reductase. Gene 148, 253-60.
20. Mai S, Hanley-Hyde J, and Fluri M (1996). c-Myc overexpression associated DHFR gene amplification in hamster, rat, mouse, and human cells. Oncogene 12, 277-88.
21. Mai S, Hanley-Hyde J, Rainey GJ, Kuschak TI, Paul JT, Littlewood TD, Mischak H, Stevens LM, Henderson DW, and Mushinski JF (1999). Chromosomal and extrachromosomal instability of the cyclin D2 gene is induced by Myc overexpression. Neoplasia 1, 241-52.
22. Kuschak TI, Taylor C, McMillan-Ward E, Israels S, Henderson DW, Mushinski JF, Wright JA, and Mai S (1999). The ribonucleotide reductase R2 gene is a non-transcribed target of c-Myc-induced genomic instability. Gene 238, 351-65.
23. Mai S, Fluri M, Siwarski D, and Huppi K (1996). Genomic instability in MycER-activated Rat1A-Myc-ER cells. Chromosome Res 4, 365-71.
24. Felsher DW, and Bishop JM (1999). Transient excess of MYC activity can elicit genomic instability and tumorigenesis. Proc Natl Acad Sci USA 76, 5669-73.
25. Vafa O, Wade M, Kern S, Beeche M, Pandita TK, Hampton GM, and Wahl GM (2002). c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability. Mol Cell 9, 1031-44.
26. Stark GR, and Wahl GM (1984). Gene amplification. Annu Rev Biochem 53, 447-91.
27. Lücke-Huhle C (1989). Review: gene amplification - a cellular response to genotoxic stress. Mol Toxicol 2, 237-53.
28. Stark GR (1993). Regulation and mechanisms of mammalian gene amplification. Adv Cancer Res 61, 87-113.
29. Taylor C, and Mai S (1998). c-Myc-associated genomic instability of the dihydrofolate reductase locus in vivo. Cancer Detect Prev 22, 350-56.
30. Taylor C, Jalava A, and Mai S (1997). c-Myc dependent initiation of genomic instability during neoplastic transformation. Curr Top Microbiol Immunol 224, 201-207.
31. Kuschak TI, Paul JT, Mushinski JF, Wright JA, and Mai S (1999). FISH on purified extrachromosomal DNA molecules. Technical Tips Online 〈http://www.biomed net.com/db/tto〉〉,t01669.
32. Kuschak TI, Kuschak BC, Taylor CL, Wright JA, Wiener F, and Mai S (2002). c-Myc initiates illegitimate replication of the ribonucleotide reductase R2 gene. Oncogene 21, 909-20.
33. Smith GM, Dushnicky L, Symons S, Wright JA, and Mai S (2001). c-Myc inducible chromosomal and extrachromosomal amplification of R2 and ODC. Proc AACR 42 (4843), 902.
34. Gaubatz JW (1990). Extrachromosomal circular DNAs and genomic sequence plasticity in eukaryotic cells. Mutat Res 237, 271-92.
35. Cohen S, Regev A, and Lavi S (1997). Small polydispersed circular DNA (spcDNA) in human cells: association with genomic instability. Oncogene 14, 977-85.
36. Regev A, Cohen S, Cohen E, Bar-Am I, and Lavi S (1998). Telomeric repeats on small polydisperse circular DNA (spcDNA) and genomic instability. Oncogene 17, 3455-61.
37. Rush MG, and Misra R (1985). Extrachromosomal DNA in eucaryotes. Plasmid 14, 177-91.
38. Alitalo K, and Schwab M (1986). Oncogene amplification in tumor cells. Adv Cancer Res 47, 235-81.
39. Wahl GM (1989). The importance of circular DNA in mammalian gene amplification. Cancer Res 49, 1333-40.
40. Hahn PJ (1993). Molecular biology of double-minute chromosomes. Bioessays 15, 477-84.
41. Kaufman RJ, Brown PC, and Schimke RT (1979). Amplified dihydrofolate reductase genes in unstably methotrexate-resistant cells are associated with double minute chromosomes. Proc Natl Acad Sci USA 76, 5669-73.
42. Von Hoff DD, Needham -Van Devanter DR, Yucel J, Windle BE, and Wahl GM (1988). Amplified human MYC oncogenes localized to replicating submicroscopic circular DNA molecules. Proc Natl Acad Sci USA 85, 4804-808.
43. Ruiz JC, Choi K, Von Hoff DD, Roninson IB, and Wahl GM (1989). Autonomously replicating episomes contains mdrl genes in a multidrug-resistant human cell line. Mol Cell Biol 9, 109-15.
44. Pauletti G, Lai E, and Attardi G (1990). Early appearance and long term persistence of the submicroscopic extrachromosomal elements (amplisomes) containing the amplified DHFR genes in human cell lines. Proc Natl Acad Sci USA 87, 2955-59.
45. Itoh N, and Shimizu N (1998). DNA replication-dependent intranuclear relocation of double minute chromatin. J Cell Sci 111, 3275-85.
46. Solovei I, Kienle D, Little G, Eils R, Savelyeva L, Schwab M, Jager W, Cremer C, and Cremer T (2000). Topology of Double Minute (dmins) and homogeneously staining regions (HSRs) in nuclei of human neuroblastoma cell lines. Genes Chromosomes Cancer 29, 297-308.
47. Zirbel RM, Mathieu UR, Kurz A, Cremer T, and Lichter P (1993). Evidence for a nuclear compartment of transcription and splicing located at chromosome domain boundaries. Chromosome Res 1, 93-106.
48. Zink D, Cremer T, Saffrich R, Fischer R, Trendelenburg MF, Ansorge W, and Stelzer EH (1998). Structure and dynamics of human interphase chromosome territories in vivo. Hum Genet 102, 241-51.
49. Rosenberg N, and Baltimore D (1976). A quantitative assay for transformation of bone marrow cells by Abelson murine leukemia virus. J Exp Med 143, 1453-63.
50. Hirt B (1967). Selective extraction of polyoma DNA from infected mouse cell cultures. J Mol Biol 26, 365-69.
51. 2 and mitosis. Cytometry 32, 71-77.
52. Laemmli UK (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-85.
53. Kuschak TI, Kuschak BC, Smith GM, Wright JA, and Mai S (2001). Isolation of extrachromosomal elements by histone immunoprecipitation. Biotechniques 30, 1064-72.
54. Bradford MM (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72, 248-54.
55. Schoenlein PV, Barrett JT, and Welter D (1999). The degradation profile of extrachromosomal circular DNA during cisplatin-induced apoptosis is consistent with preferential cleavage at matrix attachment regions. Chromosoma 108, 121-31.
56. Jack EM, Waters JJ, and Harrison CJ (1987). A scanning electron microscopy study of double minutes from a human tumour cell line. Cytogenet Cell Genet 44, 49-52.
57. Kornberg RD (1977). Structure of chromatin. Annu Rev Biochem 46, 931-54.
58. Kanda T, Sullivan KF, and Wahl GM (1998). Histone-GFP fusion protein enables sensitive analysis of chromosome dynamics in living mammalian cells. Curr Biol 8, 377-85.
59. 1 and the micronucleation by lamin reorganization at S phase. J Cell Sci 113, 697-707.
60. Hendzel MJ, and Bazett-Jones DP (1997). Fixation-dependent organization of core histones following DNA fluorescent in situ hybridization. Chromosoma 106, 114-23.
61. Benner SE, Wahl GM, and Von Hoff DD (1991). Double minute chromosomes and homogeneously staining regions in tumors taken directly from patients versus in human tumor cell lines. Anticancer Drugs 2, 11-25.
62. Slovak ML, Ho JP, Pettenati MJ, Khan A, Douer D, Lal S, and Traweek ST (1994). Localization of amplified MYC gene sequences to double minute chromosomes in acute myelogenous leukemia. Genes Chromosomes Cancer 9, 62-67.
63. Keung YK, Cobos E, Morgan D, Whitehead RP, and Tonk V (1997). Double minute chromosomes and myelodysplastic syndrome: a case report and literature review. Cancer Genet Cytogenet 97, 94-96.
64. Von Hoff DD, McGill JR, Forseth BJ, Davidson KK, Bradley TP, Van Devanter DR, and Wahl GM (1992). Elimination of extrachromosomally amplified MYC genes from human tumor cells reduces their tumorigenicity. Proc Natl Acad Sci USA 89, 8165-69.
65. Raymond E, Faivre S, Weiss G, McGill J, Davidson K, Izbicka E, Kuhn JG, Allred C, Clark GM, and Von Hoff DD (2001). Effects of hydroxyurea on extrachromosomal DNA in patients with advanced ovarian carcinomas. Clin Cancer Res 7, 1171-80.
66. Wiener F, Kuschak TI, Ohno S, and Mai S (1999). Deregulated expression of c-Myc in a translocation-negative plasmacytoma on extrachromosomal elements that carry IgH and myc genes. Proc Natl Acad Sci USA 96, 13967-72.
67. Frank SR, Schroeder M, Fernandez P, Taubert S, and Amati B (2001). Binding of c-Myc to chromatin mediates mitogens-induced acetylation of histone H4 and gene activation. Genes Dev 15, 2069-82.
68. Bouchard C, Dittrich O, Kiermaier A, Dohmann K, Menkel A, Eilers M, and Lüscher B (2001). Regulation of cyclin D2 gene expression by the Myc/Max/Mad network: Myc-dependent TRRAP recruitment and histone acetylation at the cyclin D2 promoter. Genes Dev 15, 2042-47.